Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Multiple Sclerosis Treatment and Holistic Patient Care Consensus by the Spanish Society of Neurology
Multiple Sclerosis
P3 - Poster Session 3 (5:30 PM-6:30 PM)
6-013

To approach MS effectively, recommendations, guidelines, and consensus are needed. Diagnosis, monitoring and disease treatment present several challenges. With numerous disease-modifying therapies (DMTs) available, and the lack of accurate biomarkers for predicting effectiveness and safety, therapeutic decision-making becomes challenging.

We aimed to provide a set of recommendations regarding comprehensive management of multiple sclerosis (MS) patients in Spanish clinical practice.

The Delphi methodology was used to develop the recommendations, which aimed to achieve consensus among experts based on their experience, the latest scientific evidence and the limitations of current resources. There were two rounds of evaluation, completed by 21 panelists who provided feedback on each item.

Nine dimensions of MS management are covered by the recommendations, including early diagnosis, early start of DMT, escalation versus early start of high-efficacy DMT, face-to-face and remote follow-up, suboptimal response detection, patient perspective, biomarkers and pregnancy, as well as vaccination. The panel recommends that the optic nerve lesions and a spinal MRI should be incorporated into the diagnosis to provide information to guide a therapeutic decision. Following diagnosis, the choice of initial treatment should not be based on the use of “treatment lines”, but primarily on the presence or absence of poor prognostic factors for the occurrence of relapses or disability progression. There are possibilities for telemedicine to supplement or replace some face-to-face follow-ups, but a face-to-face follow-up is recommended after starting the first DMT and in unstable patients. In women considering becoming pregnant, prior to pregnancy planning the patient should be stable and, if not, the treatment should be optimized.

This consensus provides recommendations for the comprehensive management of MS patients in Spanish clinical practice. It is expected that the recommendations will improve patient care and result in a higher quality of life for the patients.

Authors/Disclosures
Celia Oreja Guevara
PRESENTER
Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis.
Jose Meca Lallana, MD (Hospital Clinico Universitario Virgen De La Arrixaca) Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Sergio Martinez-Yelamos No disclosure on file
Sara Eichau Madueno Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Sara Eichau Madueno has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Sara Eichau Madueno has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Sara Eichau Madueno has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Sara Eichau Madueno has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck.
Miguel Angel Llaneza Gonzalez, MD (Neurologia - Hospital Arquitecto Marcide) Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi . Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Miguel Angel Llaneza Gonzalez, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Jesus Manuel Martin Martinez Jesus Manuel Martin Martinez has nothing to disclose.
Joaquin Pena Martinez Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellgene. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Joaquin Pena Martinez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Virginia Meca Lallana Virginia Meca Lallana has nothing to disclose.
Ana M. Alonso Torres, MD Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Alonso Torres has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Ester Moral No disclosure on file
Jordi I. Rio, MD The institution of Dr. Rio has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for novartis, merck, sanofi, roche. The institution of Dr. Rio has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for novartis, merck, sanofi, roche. Dr. Rio has received personal compensation in the range of $0-$499 for serving as an Expert Witness for novartis, merck, sanofi, roche.
Carmen Calles, MD (Grupo 7 Viajes) Dr. Calles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi, Biogen, Roche, Teva, Novartis, Merck. Dr. Calles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi, Teva, Biogen, Roche, Novartis, Merck.
Adrian Ares-Luque, MD Dr. Ares-Luque has nothing to disclose.
Lluis Ramió-Torrentà Lluis Ramió-Torrentà has nothing to disclose.
María Eugenia Marzo No disclosure on file
Jose M. Prieto, MD (Hospital Clínico Universitario de Santiago de Compostela) Dr. Prieto has nothing to disclose.
Maria Luisa Martinez Gines, MD Dr. Martinez Gines has nothing to disclose.
Rafael Arroyo Gonzalez Rafael Arroyo Gonzalez has nothing to disclose.
María Otano No disclosure on file
Luis Brieva Ruiz, MD (Hospital Arnau Vilanova) Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All comercial companies interested in Multiple Sclerosis. Dr. Brieva Ruiz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Al comercial companies in Multiple Sclerosis. The institution of Dr. Brieva Ruiz has received research support from Carlos III Institut. Madrid. Spain..
Montserrat Gomez Gutierrez No disclosure on file
Alfredo Rodriguez Antiguedad, MD (Hospital Universitario Cruces Neurology Department) Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for NOVARTIS. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for BIOGEN. Alfredo Rodriguez Antiguedad, MD has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for MERCK.
Victoria Galan Sanchez-Seco Victoria Galan Sanchez-Seco has nothing to disclose.
Lucienne Costa C. Franca, Sr., PhD (Hospital Universitario Ramón y Cajal) Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Almirall. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biopas. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristoll-Mayer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche.
Miguel Angel Hernandez Perez (Hospital Nuestra Senora de Candelaria) Miguel Angel Hernandez Perez has nothing to disclose.
Lamberto Landete Pascual Lamberto Landete Pascual has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK, Roche, Teva, Novartis, BMS, Janssen, Almirall, Biogen. Lamberto Landete Pascual has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK, Roche, Teva, Novartis, BMS, Janssen, Almirall, Biogen.. Lamberto Landete Pascual has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MERCK, Roche, Teva, Novartis, BMS, Janssen, Almirall, Biogen..
Monserrat Gonzalez Platas No disclosure on file